Screening for drug use can be reasonable, but not evidence-based
Little evidence supports the new recommendations for clinical screening for drug use. Do the potential benefits outweigh the potential harms?
Jun 9, 2020
1
37
Little evidence supports the new recommendations for clinical screening for drug use. Do the potential benefits outweigh the potential harms?
Jun 9, 2020
1
37
The coronavirus has the world in its grip. Finding a cure has never been more important. Unfortunately, the development of new drugs for treatment of the COVID-19 disease caused by the virus and development of a vaccine are ...
May 20, 2020
0
2
McMaster University researchers have discovered a combination punch to treat drug-resistant infections that is showing promise based on testing in mice.
May 14, 2020
0
26
A comprehensive map of genes necessary for cancer survival is one step closer, following the validation of the two largest CRISPR-Cas9 genetic screens in 725 cancer models, across 25 different cancer types. Scientists at ...
Dec 20, 2019
0
56
Researchers at the University of Illinois at Urbana-Champaign have successfully used stem cells to engineer living biohybrid nerve tissue to develop 3-D models of neural networks with the hopes of gaining a better understanding ...
Dec 11, 2019
0
130
A new screening system developed by scientists at the UCLA Jonsson Comprehensive Cancer Center leverages redundancy in an important component of a cell—nucleotide metabolism—to help identify new drugs that specifically ...
Nov 18, 2019
2
3
In spite of increasing demand, the number of newly developed drugs decreased continuously in the past decades. The search for new active substances, their production, characterization, and screening for biological effectiveness ...
Jul 15, 2019
0
24
(HealthDay)—From 2009 to 2015, the prevalence of methadone use decreased and buprenorphine use increased among Medicaid-enrolled pregnant women with opioid use disorder, and the 4Ps Plus and Substance Use Risk Profile-Pregnancy ...
Apr 12, 2019
0
4
Lung adenocarcinoma is the most common type of lung cancer. Although various targeted drugs have been developed to treat it, they do not markedly improve the survival of patients. Part of the explanation for this impasse ...
Mar 7, 2019
0
1
Universal screening of individual blood donations for Zika virus, which began in 2016, was not cost-effective in the 50 states during the first year. Widespread screening would only be cost-effective in the high mosquito ...
Jan 7, 2019
0
1